STONY BROOK, N.Y. -- (Business Wire)
Applied
DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN),
will host an investor call and simultaneous webcast on Thursday, August
10, 2017 at 4:30 PM ET to discuss its fiscal 2017 third quarter
financial results.
Dr. James Hayward, president and CEO, and Beth Jantzen, CFO, plan to
discuss the company’s performance and achievements for the quarter and
outline key ongoing business initiatives for the balance of the 2017
fiscal year. Management’s commentary will be followed by a
question-and-answer session. The investor call and webcast will be
accompanied by a PowerPoint presentation, which will be made available
on the company’s website at the start of the call.
For investors that are unable to attend the live call, call replay and
webcast information is provided below.
To Participate:
Dial-in and ask to be joined to the Applied DNA Sciences earnings call.
Replay (available 1 hour following the conclusion of the live call):
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.
We make life real and safe by providing innovative, molecular-based
technology solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies,
governments and consumers from theft, counterfeiting, fraud and
diversion. The proprietary DNA-based “CertainT™” platform can be used to
identify, tag, test, and track products, to help assure authenticity,
origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the
heart of a family of uncopyable, security and authentication solutions
such as SigNature® T and fiberTyping®, targeted toward textiles and
apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and
digitalDNA®, providing powerful track-and-trace. All provide a forensic
chain of evidence, and can be used to prosecute perpetrators. Applied
DNA Sciences is also engaged in the large-scale production of specific
DNA sequences using the polymerase chain reaction.
Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.
Forward-Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN’s
future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ
materially from those projected due to our short operating history,
limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in
APDN’s SEC reports and filings, including our Annual Report on Form 10-K
filed on December 6, 2016, and our subsequent quarterly reports on Form
10-Q filed on February 9, 2017, and May 11, 2017 which are available at www.sec.gov.
APDN undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170727005108/en/
Contacts:
Investors:
LHA Investor Relations
Sanjay M. Hurry,
212-838-3777
shurry@lhai.com
or
web: www.adnas.com
twitter:
@APDN
Source: Applied DNA Sciences
© 2024 Canjex Publishing Ltd. All rights reserved.